Hôpital Nord

Futó vizsgálatok

• Még nem toboroz

  Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty

  NCT07644377· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· 1/2. fázis· Daiichi Sankyo· Forrás

• Még nem toboroz

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Fondation Hôpital Saint-Joseph· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  ActiTENS Mini (Transcutaneous Electrical Stimulation) in Women With Chronic Pain From Pelvic Endometriosis

  NCT07317037· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease

  NCT07629245· 1/2. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Toboroz

  Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  NCT07185997· 3. fázis· ArriVent BioPharma, Inc.· Forrás

• Toboroz

  Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

  NCT07563205· GFPC Investigation· Forrás

• Toboroz

  Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

  NCT06745908· 3. fázis· ImmunityBio, Inc.· Forrás

• Toboroz

  Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology

  NCT06805890· Assistance Publique Hopitaux De Marseille· Forrás

• Toboroz

  Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)

  NCT07243132· GFPC Investigation· Forrás

• Toboroz

  Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

  NCT06620835· 2. fázis· Groupe Francais De Pneumo-Cancerologie· Forrás

• Toboroz

  Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245· 3. fázis· OSE Immunotherapeutics· Forrás

• Toboroz

  FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

  NCT06669117· 1/2. fázis· Pierre Fabre Medicament· Forrás

• Toboroz

  National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

  NCT06356831· Centre Hospitalier Intercommunal Creteil· Forrás

• Toboroz

  FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

  NCT06393816· 2. fázis· Centre Leon Berard· Forrás

• Fut, nem toboroz

  Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

  NCT05930275· AbbVie· Forrás

• Toboroz

  Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)

  NCT06154785· Bordeaux Colorectal Institute Academy· Forrás

• Toboroz

  Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

  NCT06420505· Translumina GmbH· Forrás

• Toboroz

  G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-through

  NCT06068127· Institute for Clinical and Experimental Medicine· Forrás

• Toboroz

  A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  NCT05967689· 2. fázis· Taiho Oncology, Inc.· Forrás

• Toboroz

  Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

  NCT04020263· 3. fázis· Pr Bruno LEVY· Forrás

• Fut, nem toboroz

  An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

  NCT05841537· AbbVie· Forrás

• Toboroz

  Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

  NCT05521776· Assistance Publique - Hôpitaux de Paris· Forrás

• Fut, nem toboroz

  An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

  NCT05363319· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

  NCT05494606· AbbVie· Forrás

• Toboroz

  Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

  NCT04749108· 2/3. fázis· Institut du Cancer de Montpellier - Val d'Aurelle· Forrás

• Toboroz

  Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

  NCT05122806· Groupe Francais De Pneumo-Cancerologie· Forrás

• Toboroz

  Molecular Signature From Tumor to Lymph Nodes

  NCT04677205· Assistance Publique - Hôpitaux de Paris· Forrás

• Fut, nem toboroz

  Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

  NCT05049044· Groupe Francais De Pneumo-Cancerologie· Forrás

• Fut, nem toboroz

  A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

  NCT03148418· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

  NCT03022188· Société Française d'Endoscopie Digestive· Forrás

• Fut, nem toboroz

  Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

  NCT02568267· 2. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Biological and Clinical Database for Pancreatic Adenocarcinoma

  NCT02818829· University Hospital, Toulouse· Forrás

• Fut, nem toboroz

  Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

  NCT02089100· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Meghívásos bevonás

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Michaël Hofer· Forrás

• Fut, nem toboroz

  A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

  NCT01957436· 3. fázis· UNICANCER· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák12 toboroz
• Crohn-betegség3 toboroz
• Vastagbélrák2 toboroz
• Colitis ulcerosa1 toboroz
• Endometriózis1 toboroz
• Gastroparesis1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Koszorúér-betegség1 toboroz
• Magas vérnyomás1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Rheumatoid arthritis1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Lezárult

  Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference

  NCT03960112· Institut Paoli-Calmettes· Forrás

• Leállították

  CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

  NCT05546606· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Groupe Francais De Pneumo-Cancerologie· Forrás

• Lezárult

  Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing

  NCT04308603· Hospices Civils de Lyon· Forrás

• Lezárult

  A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer

  NCT04620330· 2. fázis· Verastem, Inc.· Forrás

• Lezárult

  Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

  NCT04233021· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Leállították

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· 3. fázis· University Hospital, Brest· Forrás

• Lezárult

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Regeneron Pharmaceuticals· Forrás

• Lezárult

  BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

  NCT03762018· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

• Lezárult

  Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

  NCT03829319· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

  NCT03357562· University Hospital, Bordeaux· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

  NCT03006432· 3. fázis· Federation Francophone de Cancerologie Digestive· Forrás

• Lezárult

  Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

  NCT02784171· 2/3. fázis· Canadian Cancer Trials Group· Forrás

• Lezárult

  Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

  NCT02738125· AbbVie· Forrás

• Lezárult

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer

  NCT02359968· 2. fázis· Centre Oscar Lambret· Forrás

• Lezárult

  SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients

  NCT02117167· 2. fázis· UNICANCER· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Pfizer· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Lyme disease3 munka · 0 vizsgálat
• Gastroparesis3 munka · 1 vizsgálat